Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-10-24

Clinical Trial Update: Study of FLUTIFORM® VS Seretide® in Paediatric Subjects With Asthma [Phase 3]

View source ↗

Summary

Phase 3 trial comparing FLUTIFORM against Seretide in paediatric asthma completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FlutiForm (fluticasone propionate/formoterol)
  • Seretide (fluticasone propionate/salmeterol)

Snippet

Sponsor: Mundipharma Research Limited | Conditions: Asthma | Phase 3 | Status: COMPLETED